First-in-human clinical trial underway to evaluate safety, tolerability and pharmacodynamic activity of HB2198 in normal healthy volunteers.
Once built to fight cancer, CAR‑T therapy is now offering new hope for patients with severe autoimmune disease.
B-cell acute lymphoblastic leukemia is the most common form of childhood cancer. In this type of cancer, which affects blood ...
CAR-T cell therapy, originally developed for cancer, is showing ever more promise as a treatment for autoimmune diseases.
Fourteen months after treatment with engineered immune cells, the recipient has no symptoms and doesn’t need to take ...
CAR-T cell therapy, originally developed for cancer, is showing ever more promise as a treatment for autoimmune diseases.
For the first time, scientists have used a modern cell therapy called CAR-T to treat a patient with three different ...
A woman who lived with three different life-threatening autoimmune diseases for more than a decade has made a “remarkable” ...
FDA fully approves brexu-cel CAR‑T for relapsed mantle cell lymphoma, with ZUMA‑2 showing deep responses and key ...
It was actually scary how not afraid of anything she was,” Kati Still said about her four-year-old daughter Emmalyn “Emmy” ...
Verizon Communications customers across the United States are not experiencing a widespread service outage Saturday, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results